Newborn infants with "early-onset" disease due to group B beta hemolytic streptococcus were studied over a 40-month period. Clinical presentations included asymptomatic bacteremia, mild transient illness, respiratory distress, meningitis, and overwhelming sepsis. Chronologically, 19 were ill at birth; 11 became ill after a symptom-free period; and four were asymptomatic. Sixty-eight percent of the cases weighed less than 2500 grams, and 59 percent were born to mothers whose amniotic membranes were ruptured for over 20 hours. The overall "early-onset" attack rate was 1.9/1000 live births, but the rates increased markedly with decreasing birth weight, i.e., for infants weighing > 2.5 kg, 0.811000; 2-2.5 kg, 511000; 1-2 kg, 11.2/1000; and .5-1 kg. 6611000 live births. respectively. Similarly, the attack rates increased with the duration of ruptured membranes. from 0.711000 for.0-9 hrs. 111000 for 10-19 hrs. 1711000 for 20-29 hrs, to 2111000 for > 30 hrs. All 15 of the deaths occurred in the low birth weight infants who were critically ill from birth. These results suggest that the management of "early-onset" disease should begin prior to delivery and focus on high risk groups. The colonized gravid woman in premature labor or with prolonged ruptured membranes is clearly at risk, and a controlled study of penicillin prophylaxis appears indicated. Repliention rxneriments in vitro have heen rmplnvrd an n hlolopical ansav nvstem to ascertain defectjvmrsn nnd the emresion of viral intrrferrncr for qtrain~ of wild mlnpn virnn, hiph pansage cell culture-ndnnted lahorntorv virlrs. and nttenllnted vaccine vinlq.
The efficiencv of viral rcplicatio~ (mP) was determined by compnrino the nu1 tfrllcitv of infrcrion (Pax) witlr thr vultjrl ic-
Serfnl nnsnape of pnrtinllv pllrifled, cloned 1al)orntory virtm demnstrnted o stril4no l o r r m~e in TOP durinp enrlv cycles wlth nuhsen~~ent decllnc---tlie clao~ic Von Elnpnrtn pl~enomenon of defective viral intcrferrnce. Thr r~plicn-tion bin~tles of wild, 1al.nratorv and varcine vlr~~n werr evaluated usinp repulnr qtocl. nncl cloned ~o o l s nf vlr~m. The rnl: for stock wild virus rns &-fold crrnter thrn stnrl, vrcrirc virus and 300-fold prrntcr thnn ntock lnhoratorv vfru?. 7sr FOR for vncclne and lshoratorv virus wns incrennrd strfl ionlv bv dooblc cloninr, whtlr nrlclt llmitlnr dilution bmndnorptjnn nlnsr~frr trcl~ninurs mploved to eliminate defcctjve virionn hnd little im pnct upon tl~c FfiP of wild virus.
Defective virions nlnv an importnnt role tn tlir develorment of persfntent. n l w vlrlln tnfectionn. 1Y1d rmrmps virucl srem unliLelv to product= atlcb a nnrhol iolopir pmress. limsevrr thrrr may he some concern nhout nttcnunted mlmnn virun vnccfnr. GBS pneumonia in the newborn is often fatal despite early treatment. Three infants with GBS pneumonia and sepsis were studied to define the role of immunoglobulins (Ig) and complement (C) in the development of this disease. Cord blood samples from 2 of the 3 infants had been obtained and were found to contain antibodies to GBS, but normal C levels. Serum C levels were obtained from all 3 infants during illness, at which time C3, C4 and Factor B (B) were depressed. Necropsy lung specimens from the 3 infants were studied by light microscopy. PAS positive hyaline membranes were observed in alveoli and gram stains showed gram positive cocci. Lung specimens were also snap-frozen for immunofluorescence (IF) with antisera to Ig, C and fibrin. Deposits of IgG, C3, C4 and fibrin were observed in the alveolar hyaline membranes. IF ataining for GBS organisms and B was distributed throughout the lung parenchyma. IF for IgM was negative in all patients. Specimens taken from three infants who died from other causes did not show theae patterns of staining. C3. C4 and B IF staining in lungs associated with serum C depression in patients with GBS pneumonia suggests activation of classical and alternative C pathways in this illness. In addition, the presence of IgG. C3 and C4 in the alveolar membranes suggests that maternal IgG may contribute to immune complex deposition as part of the pathogenesis of this disease, and further suggests that treatment other than antibiotics should be considered. Cowan I strain of Staphylococcus aureus contains a cell wall substance, protein A, which can absorb most of the IgG fromhrman serum; IgM, IgA, and IgD remain practically unaffected. In the present study, acute sera from children who received killed AlNew Jersey176 influenza virus vaccine were absorbed with S. aureus (Cowan I). An aliquot of the serum was also absorbed with S. aureus (Wood), a strain which does not contain protein A. A third aliquot was left unabsorbed. Hemagglutination-inhibiting (HAI) antibodies to AlNew Jersey176 antigen were determined on the three serum aliquots in tandem. The unabsorbed sera and sera which were absorbed with S. aureus (Wood) had comparable HA1 antibody titers. The sera of 11 of 14 children had en eight-fold or less decline in HA1 antibody titer after absorption with S. aureus (Cowan I); the sera of two other children decreased sixteen-fold. Only one child's serum had no detectable HA1 antibodies after the absorption procedure with S. aureus (Cowan I). In contrast, the latter absorption completely removed HA1 antibodies from the sera of a control group who had long-standing antibodies to AINew Jersey176 (or an antigenically similar virus). The acute sera of the vaccinees which still contained HA1 antibodies after S. aureus (Cowan I) absorption suggests the presence of specific 1gM andlor IgA antibodies. This relatively simple absorption procedure performed on a single serum may be useful for the detection of an acute influenza1 infection. Although it has been recoomended that children with malignant diseases be immunized against influenza, few data ere available to indicate the inmune response or reactions that might be expected from this group. In this study. 46 children with malignant diseases received varying dosages of killed split or whole bivalent (A/New Jersey176 and A/Victoria/75) influenza vaccine or a placebo by the intramuscular route. Two doses were administered four weeks apart. The children were receiving standard cancer chemotherapy regimens of the Children's Cancer Study Group. The response to immunization in the children with malignant diseases was similar to that found in normal children who received aliquots of the same antigen preparations as killed monovalent AINew Jersey/76 vaccine. Reactions after vaccine administration were minimal. It is concluded that the dose of influenza antigen in the vaccine recoomended for normal children would appear to be appropriate for children with malignant diseases. In addition to immunization against AINew Jersey176 it has been recarmended that the children with malignant diseases receive antigen preparations of other prevalent influenza1 strains.
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